Morocco’s pharmaceutical industry has seen a sharp rise in exports over the past few years, signaling the country’s growing presence on the global health stage. Between 2020 and 2024, the value of pharmaceutical exports climbed from 1.1 billion to 1.5 billion dirhams, reflecting an average annual growth rate of 8%. This steady progress has helped Morocco carve out a stronger position in African markets, where its export share has nearly doubled over the past decade—from 6% in 2011 to 11% in 2024. As a result, Morocco now ranks fourth among the top pharmaceutical exporters on the continent.
At the heart of this success is a robust domestic manufacturing base made up of over sixty pharmaceutical production facilities. All of them meet both European and American regulatory standards, enabling the sector to cover roughly 70% of the country’s internal pharmaceutical demand while also exporting to around forty countries. These destinations span across Africa, Europe, and the MENA region. Collectively, the industry now generates more than 13.7 billion dirhams in annual revenue.
Morocco’s pharmaceutical ecosystem is structured around two main pillars: drug manufacturing and medical devices. This dual focus is supported by a regulatory framework aligned with global benchmarks, boosting the country’s competitiveness in areas like generic medications, vaccines, and medical equipment. The alignment with international standards has also opened the door for greater global partnerships and market access.
The COVID-19 pandemic served as a critical test of Morocco’s industrial agility. In response to the crisis, the country quickly mobilized its resources to produce essential health items such as masks, hand sanitizers, diagnostic tests, and vital medications—all within its own borders. Beyond addressing its own needs, Morocco extended a helping hand to several partner nations, supplying not only health products but also technical expertise.
These achievements are closely tied to the broader goals of the United Nations’ Sustainable Development Goal 3, which promotes good health and well-being. At the same time, Morocco is taking steps to minimize the environmental footprint of its pharmaceutical sector. Initiatives are underway to improve waste management, cut carbon emissions, and promote responsible use of natural resources, ensuring that growth in the health industry doesn’t come at the planet’s expense.
